Literature DB >> 2803934

Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.

P Lissoni1, S Barni, R Rescaldani, F Rovelli, G Tancini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2803934      PMCID： PMC2247096          DOI： 10.1038/bjc.1989.325

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

1.  Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival.

Authors:  D K Wagner; J Kiwanuka; B K Edwards; L A Rubin; D L Nelson; I T Magrath
Journal:  J Clin Oncol       Date:  1987-08       Impact factor: 44.544

2.  Immunoincompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations.

Authors:  R O Dillman; J A Koziol; M I Zavanelli; J C Beauregard; B L Halliburton; M C Glassy; I Royston
Journal:  Cancer       Date:  1984-04-01       Impact factor: 6.860

3.  The released interleukin 2 receptor binds interleukin 2 efficiently.

Authors:  L A Rubin; G Jay; D L Nelson
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

4.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

5.  Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia.

Authors:  M Chilosi; G Pizzolo; G Semenzato; G L Cetto
Journal:  Int J Biol Markers       Date:  1986 May-Aug       Impact factor: 3.248

6.  Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.

Authors:  G Pizzolo; M Chilosi; F Vinante; F Dazzi; M Lestani; G Perona; F Benedetti; G Todeschini; C Vincenzi; L Trentin
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640
  6 in total
  2 in total

1.  Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.

Authors:  S Mariotti; G Barbesino; P Caturegli; M Marinò; L Manetti; L Fugazzola; F Pacini; A Pinchera
Journal:  J Endocrinol Invest       Date:  1994-12       Impact factor: 4.256

2.  Spontaneous regression of metastatic renal cell carcinoma following palliative irradiation of the primary tumour.

Authors:  M P MacManus; R J Harte; S Stranex
Journal:  Ir J Med Sci       Date:  1994-10       Impact factor: 1.568
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.